Correlation Between Verve Therapeutics and Bright Minds

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verve Therapeutics and Bright Minds Biosciences, you can compare the effects of market volatilities on Verve Therapeutics and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Bright Minds.

Diversification Opportunities for Verve Therapeutics and Bright Minds

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Verve and Bright is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Bright Minds go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Bright Minds

Given the investment horizon of 90 days Verve Therapeutics is expected to under-perform the Bright Minds. But the stock apears to be less risky and, when comparing its historical volatility, Verve Therapeutics is 8.48 times less risky than Bright Minds. The stock trades about -0.02 of its potential returns per unit of risk. The Bright Minds Biosciences is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  520.00  in Bright Minds Biosciences on August 30, 2024 and sell it today you would earn a total of  3,398  from holding Bright Minds Biosciences or generate 653.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verve Therapeutics  vs.  Bright Minds Biosciences

 Performance 
       Timeline  
Verve Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Bright Minds Biosciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Bright Minds reported solid returns over the last few months and may actually be approaching a breakup point.

Verve Therapeutics and Bright Minds Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verve Therapeutics and Bright Minds

The main advantage of trading using opposite Verve Therapeutics and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.
The idea behind Verve Therapeutics and Bright Minds Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like